Your browser doesn't support javascript.
loading
An Innovative Polymer-Based Electrochemical Sensor Encrusted with Tb Nanoparticles for the Detection of Favipiravir: A Potential Antiviral Drug for the Treatment of COVID-19.
Ali, Marwa F B; Saraya, Roshdy E; El Deeb, Sami; Ibrahim, Adel Ehab; Salman, Baher I.
Afiliación
  • Ali MFB; Department of Pharmaceutical Analytical Chemistry, Faculty of Pharmacy, Assiut University, Assiut 71526, Egypt.
  • Saraya RE; Pharmaceutical Analytical Chemistry Department, Faculty of Pharmacy, Port-Said University, Port Said 42526, Egypt.
  • El Deeb S; Institute of Medicinal and Pharmaceutical Chemistry, Teschnische Universität Braunschweig, 38106 Braunschweig, Germany.
  • Ibrahim AE; Natural and Medical Sciences Research Center, University of Nizwa, Birkat Al Mauz, P.O. Box 33, Nizwa 616, Oman.
  • Salman BI; Pharmaceutical Analytical Chemistry Department, Faculty of Pharmacy, Port-Said University, Port Said 42526, Egypt.
Biosensors (Basel) ; 13(2)2023 Feb 08.
Article en En | MEDLINE | ID: mdl-36832009
ABSTRACT
An innovative polymer-based electro-sensor decorated with Tb nanoparticles has been developed for the first time. The fabricated sensor was utilized for trace determination of favipiravir (FAV), a recently US FDA-approved antiviral drug for the treatment of COVID-19. Different techniques, including ultraviolet-visible spectrophotometry (UV-VIS), cyclic voltammetry (CV), scanning electron microscope (SEM), X-ray Diffraction (XRD) and electrochemical impedance spectroscopy (EIS), were applied for the characterization of the developed electrode TbNPs@ poly m-THB/PGE. Various experimental variables, including pH, potential range, polymer concentration, number of cycles, scan rate and deposition time, were optimized. Moreover, different voltammetric parameters were examined and optimized. The presented SWV method showed linearity over the range of 10-150 × 10-9 M with a good correlation coefficient (R = 0.9994), and the detection limit (LOD) reached 3.1 × 10-9 M. The proposed method was applied for the quantification of FAV in tablet dosage forms and in human plasma without any interference from complex matrices, obtaining good % recovery results (98.58-101.93%).
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Nanopartículas / COVID-19 Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Revista: Biosensors (Basel) Año: 2023 Tipo del documento: Article País de afiliación: Egipto Pais de publicación: CH / SUIZA / SUÍÇA / SWITZERLAND

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Nanopartículas / COVID-19 Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Revista: Biosensors (Basel) Año: 2023 Tipo del documento: Article País de afiliación: Egipto Pais de publicación: CH / SUIZA / SUÍÇA / SWITZERLAND